Cargando…

Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol

BACKGROUND: The cannabis extract nabiximols (Sativex®) effectively supresses withdrawal symptoms and cravings in treatment resistant cannabis dependent individuals, who have high relapse rates following conventional withdrawal treatments. This study examines the efficacy, safety and cost-effectivene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhardwaj, Anjali K., Allsop, David J., Copeland, Jan, McGregor, Iain S., Dunlop, Adrian, Shanahan, Marian, Bruno, Raimondo, Phung, Nghi, Montebello, Mark, Sadler, Craig, Gugusheff, Jessica, Jackson, Melissa, Luksza, Jennifer, Lintzeris, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960200/ https://www.ncbi.nlm.nih.gov/pubmed/29776349 http://dx.doi.org/10.1186/s12888-018-1682-2

Ejemplares similares

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
por: Mills, Llewellyn, et al.
Publicado: (2022)

The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients
por: Jackson, Melissa A., et al.
Publicado: (2021)

Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
por: Swift, Wendy, et al.
Publicado: (2013)

Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience
por: D’hooghe, Marie, et al.
Publicado: (2021)

Correlation of Nabiximols Dose to Steady-State Concentrations of Cannabinoids in Urine Samples from Patients with Multiple Sclerosis
por: Birke, Rüdiger, et al.
Publicado: (2022)

LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence
por: Ezard, Nadine, et al.
Publicado: (2018)

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)
por: Mersiades, Antony J, et al.
Publicado: (2018)

Medical cannabis use in Australia: consumer experiences from the online cannabis as medicine survey 2020 (CAMS-20)
por: Lintzeris, Nicholas, et al.
Publicado: (2022)

A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma
por: Twelves, Chris, et al.
Publicado: (2021)

Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial
por: Trigo, Jose M., et al.
Publicado: (2018)

Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
por: Suraev, A., et al.
Publicado: (2018)

Cannabis, cannabinoids, and health
por: Lafaye, Genevieve, et al.
Publicado: (2017)

Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)
por: Lintzeris, Nicholas, et al.
Publicado: (2020)

Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey
por: Suraev, Anastasia, et al.
Publicado: (2023)

Author Correction: Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
por: Suraev, A., et al.
Publicado: (2018)

Introduction to Cannabis and Cannabinoid Research
por: Piomelli, Daniele
Publicado: (2016)

The nephrologist's guide to cannabis and cannabinoids
por: Rein, Joshua L.
Publicado: (2020)

Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials
por: Arkell, Thomas R., et al.
Publicado: (2021)

Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care
por: Abrams, Donald I.
Publicado: (2022)

Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity
por: Gajofatto, Alberto, et al.
Publicado: (2023)

Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey
por: Arkell, Thomas R., et al.
Publicado: (2023)

Research Progress on Cannabinoids in Cannabis (Cannabis sativa L.) in China
por: Sun, Xiangping
Publicado: (2023)

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
por: Arkell, Thomas R., et al.
Publicado: (2019)

Impact of Cannabis, Cannabinoids, and Endocannabinoids in the Lungs
por: Turcotte, Caroline, et al.
Publicado: (2016)

Medicinal Cannabis and Synthetic Cannabinoid Use
por: Pichini, Simona, et al.
Publicado: (2020)

Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases
por: Gonen, Tal, et al.
Publicado: (2020)

Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis
por: Radwan, Mohamed M., et al.
Publicado: (2021)

Use of Cannabis and Cannabinoids for Treatment of Cancer
por: Cherkasova, Viktoriia, et al.
Publicado: (2022)

Can Prescribed Cannabinoids Substitute Cannabis?
por: Batalla, A.
Publicado: (2022)

Modulation of type 1 cannabinoid receptor activity by cannabinoid by-products from Cannabis sativa and non-cannabis phytomolecules
por: Zagzoog, Ayat, et al.
Publicado: (2022)

Detection of Δ(9) THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point‐of‐collection testing devices
por: Arkell, Thomas R., et al.
Publicado: (2019)

Quantifying the Clinical Significance of Cannabis Withdrawal
por: Allsop, David J., et al.
Publicado: (2012)

Medicinal use of cannabis based products and cannabinoids
por: Freeman, Tom P, et al.
Publicado: (2019)

Cannabinoids, Medical Cannabis, and Colorectal Cancer Immunotherapy
por: Zaiachuk, Mariia, et al.
Publicado: (2021)

Special Issue: Therapeutic Potential for Cannabis and Cannabinoids
por: Raup-Konsavage, Wesley M.
Publicado: (2023)

Prescribing medicinal cannabis
por: Arnold, Jonathon C, et al.
Publicado: (2020)

A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain
por: Überall, Michael A
Publicado: (2020)

Tic Reduction in Adult Onset Gilles De La Tourette Syndrome Using as Required Nabiximols Spray
por: Schwittay, Maximilian A., et al.
Publicado: (2021)

Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study
por: Rosa, Gian Marco, et al.
Publicado: (2022)

Uso terapéutico del cannabis y los cannabinoides
por: Guy, Geoffrey W.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_mpc69q1h0icop0fkf07ejunj8c